Skip to main content

Notice on the Public Offering of the Shares of Liven AS

Liven AS (registry code 12619609, address Telliskivi tn 60/5, 10412, Tallinn, Estonia; Liven or the Company) hereby announces a public offering of its shares (the Offering). The Offering will be carried out based on the prospectus prepared by Liven and approved by the Estonian Financial Supervision and Resolution Authority (EFSA) on 22 April 2026, which has been published on the date of this notice on the websites of Liven and the EFSA (the Prospectus). The details of the Offering are set out in the Prospectus. For interested parties, Liven will organise a webinar in English, introducing the Company and the Offering on 29 April at 11:00 and a seminar in Estonian on 29 April at 17:30 at Liven’s Regati pst 3 / 5 development at Regati pst 5, Tallinn (ground floor; gathering and the opportunity to visit the Regati pst 5 premises begins at...

Continue reading

Harju Elekter Group financial results, 1-3/2026

The first quarter of Harju Elekter proved significantly more challenging than anticipated, and the results did not meet expectations. While the strong order book at the beginning of the year provided a basis for steady growth, several factors hindered the planned course of activities and affected the ability to fulfil orders within the agreed timeframes. The primary reason for the weak financial performance included disruptions in the supply chain – deliveries of various materials and components were delayed or postponed by manufacturers, which in turn caused the fulfilment of orders to shift into future periods. Although the order book remains substantial, rapid cost reduction is not possible without risking the ability to respond quickly enough to a subsequent increase in demand. Retaining competence, ensuring team readiness, and maintaining...

Continue reading

Altimmune Announces Pricing of $225 Million Oversubscribed Public Offering of Securities

GAITHERSBURG, Md., April 22, 2026 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced the pricing of its previously announced underwritten public offering consisting of (i) 64,250,000 shares of its common stock and accompanying common stock warrants to purchase an aggregate of 64,250,000 shares of common stock (or pre-funded warrants in lieu thereof) and (ii) in lieu of common stock, to certain investors that so choose, pre-funded warrants to purchase an aggregate of up to 10,750,000 shares of its common stock and accompanying common stock warrants to purchase an aggregate of 10,750,000 shares of common stock (or pre-funded warrants in lieu thereof), at an exercise price of $0.001 per pre-funded warrant. The common...

Continue reading

Discovery Produces 60,269 Ounces of Gold in First Quarter 2026

Company on track to achieve full-year 2026 guidance of 260,000 – 300,000 ounces TORONTO, April 22, 2026 (GLOBE NEWSWIRE) — Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today announced that the Company’s Porcupine operations (the “Porcupine Operations” or “Porcupine”) produced 60,269 ounces of gold in the first quarter of 2026 (“Q1 2026”). The Company remains on track for total gold production in 2026 of 260,000 – 300,000 ounces. As previously reported, quarterly gold production in 2026 is expected to increase as the year progresses reflecting the ramp up of mill throughput and production at the Hollinger open pit, as well as the favourable impact of investments to optimize the Company’s current mining operations. All dollar amounts are in US dollars, unless otherwise noted. Q1 2026 Key HighlightsGold...

Continue reading

Traction Uranium Files Amended and Restated LIFE Offering Document

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, April 22, 2026 (GLOBE NEWSWIRE) — Traction Uranium Corp. (CSE: TRAC) (OTC: TRCTF) (FRA: Z1K) (the “Company” or “Traction”) announces that it has filed an amended and restated offering document dated April [20], 2026 (the “Amended and Restated Offering Document”) pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106 – Prospectus Exemptions, as amended by Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption (the “Blanket Order”). The Amended and Restated Offering Document was filed after the Company satisfactorily addressed regulatory comments regarding the Company’s reliance on the Blanket Order. For more information about...

Continue reading

Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)

CHICAGO, April 22, 2026 (GLOBE NEWSWIRE) — Exicure, Inc. (Nasdaq: XCUR) today announced that it has entered into a co-development agreement with Adbiotech Co., Ltd. (KOSDAQ: 179530), a Korea-based biotechnology company, to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. The collaboration will focus on evaluating combination strategies involving Burixafor (GPC-100) in indications including sickle cell disease (SCD), acute myeloid leukemia (AML), and solid tumors. Under the agreement, Adbiotech will conduct in vivo studies and support preclinical validation and translational research, while Exicure will provide Burixafor and lead clinical and regulatory strategy. Burixafor successfully completed a Phase 2 clinical trial in multiple myeloma last year, providing a foundation for further...

Continue reading

Perseus Reports Strong Operational Performance

Perth, April 23, 2026 (GLOBE NEWSWIRE) — MARCH 2026 QUARTER REPORT Perseus reports strong operational performance; cash & bullion rises to US$817 million PERTH, Western Australia/April 23, 2026/Perseus Mining Limited (“Perseus” or the “Company”) (TSX & ASX: PRU) reports on its activities for the three months’ period ended March 31, 2026 (the “Quarter”). Below is a summary of the release. The full report is available at www.perseusmining.com, www.sedarplus.ca and www.asx.com.au. OverviewQ3 FY26 production totalled 107,144 ounces of gold at an All-In Site Costs of US$1,748 per ounce Average cash margin of US$2,395/oz of gold produced, delivering notional operating cashflow of US$252 million Cash and bullion of US$817 million, plus liquid listed securities of US$254 million First gold produced from CMA Underground at...

Continue reading

Century Next Financial Corporation Reports 1st Quarter 2026 Results

RUSTON, La., April 22, 2026 (GLOBE NEWSWIRE) — Century Next Financial Corporation (the “Company”) (OTCQX: CTUY), the holding company of Century Next Bank, with $913.7 million in assets, today announced financial results for the 1st quarter ended March 31, 2026. Financial Performance For the three months ended March 31, 2026, the Company had net income after tax of $3.55 million compared to net income of $3.45 million for the three months ended March 31, 2025, an increase of $99,000 or 2.9%. Earnings per share (EPS) for the three months ended March 31, 2026 were $1.92 per basic and $1.89 diluted share compared to $1.89 per basic and 1.88 per diluted share reported for the three months ended March 31, 2025. Balance Sheet Overall, total assets increased by $36.8 million or 4.2% to $913.7 million at March 31, 2026 compared to $876.9...

Continue reading

Clearfield Sets Fiscal Second Quarter 2026 Earnings Call for Wednesday, May 6, 2026

MINNEAPOLIS, April 22, 2026 (GLOBE NEWSWIRE) — Clearfield, Inc. (NASDAQ: CLFD), the leader in community broadband fiber connectivity, today announced that it will release results for the second quarter of fiscal 2026, ended March 31, 2025, on Wednesday, May 6, 2026, after the close of the market. The company will host a conference call at 5:00 p.m. Eastern time (4:00 p.m. Central time) to discuss its financial results with the investment community. Financial results will be available on the Investor Relations section of the company’s website along with a shareholder letter. Date: Wednesday, May 6, 2026Time: 5:00 p.m. Eastern time (4:00 p.m. Central time)U.S. dial-in: 1-844-826-3033International dial-in: 1-412-317-5185 The conference call will be webcast live and available for replay here. An audio replay of the call will be available...

Continue reading

SOUTHERN MISSOURI BANCORP REPORTS PRELIMINARY RESULTS FOR THIRD QUARTER OF FISCAL 2026; DECLARES QUARTERLY DIVIDEND OF $0.25 PER COMMON SHARE; CONFERENCE CALL SCHEDULED FOR THURSDAY, APRIL 23, AT 9:30 AM CENTRAL TIME

Poplar Bluff, Missouri, April 22, 2026 (GLOBE NEWSWIRE) — Southern Missouri Bancorp, Inc. (“Company”) (NASDAQ: SMBC), the parent corporation of Southern Bank (“Bank”), today announced preliminary net income for the third quarter of fiscal 2026 of $17.8 million, an increase of $2.1 million, or 13.3%, as compared to the same period of the prior fiscal year. The increase was attributable to increases in net interest income and noninterest income, partially offset by increases in provision for credit losses (PCL), noninterest expense, and income tax expense. Preliminary net income was $1.60 per fully diluted common share for the third quarter of fiscal 2026, an increase of $0.21 as compared to the $1.39 per fully diluted common share reported for the same period of the prior fiscal year.    Highlights for the third quarter of fiscal...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.